ALMS

Alumis Inc

• Seeking Alpha·09/18 14:20

  10 small-cap U.S. healthcare stocks with the weakest momentum grades

• Simply Wall St·09/11 20:22

  Alumis (ALMS), What Is Behind The Fresh Attention?

• NASDAQ·09/10 14:44

  Thursday 9/10 Insider Buying Report: ALMS, PRTS

• TipRanks·09/09 17:15

  Wells Fargo Sticks to Its Buy Rating for Alumis Inc. (ALMS)

• Simply Wall St·09/07 19:28

  Alumis (ALMS) Is Down 49.1% After Mixed LUMUS Trial Data Reshapes Envudeucitinib’s Precision-Medicine Path

• Simply Wall St·09/04 07:32

  Alumis (ALMS) After The Lupus Trial Miss, Is A 3.3x P B Premium Too Rich?

• TipRanks·09/03 14:30

  Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)

• Dow Jones·09/03 13:46

  Alumis Cut to Neutral From Buy by Guggenheim

• Benzinga·09/03 13:36

  Guggenheim Downgrades Alumis to Neutral

• Seeking Alpha·09/03 12:57

  Alumis downgraded at Guggenheim after trial setback for SLE candidate

• TipRanks·09/03 09:40

  Alumis downgraded to Neutral from Buy at Guggenheim

• TipRanks·09/03 09:40

  Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Alumis Inc. (ALMS)

• Dow Jones·09/02 17:02

  Alumis Is Maintained at Outperform by Oppenheimer

• Dow Jones·09/02 17:02

  Alumis Price Target Cut to $37.00/Share From $55.00 by Oppenheimer

• Benzinga·09/02 16:51

  Oppenheimer Maintains Outperform on Alumis, Lowers Price Target to $37